vs

Side-by-side financial comparison of Aterian, Inc. (ATER) and CRYO CELL INTERNATIONAL INC (CCEL). Click either name above to swap in a different company.

Aterian, Inc. is the larger business by last-quarter revenue ($15.1M vs $7.8M, roughly 1.9× CRYO CELL INTERNATIONAL INC). CRYO CELL INTERNATIONAL INC runs the higher net margin — -48.7% vs -52.5%, a 3.8% gap on every dollar of revenue. On growth, CRYO CELL INTERNATIONAL INC posted the faster year-over-year revenue change (-2.3% vs -38.5%). CRYO CELL INTERNATIONAL INC produced more free cash flow last quarter ($1.2M vs $-1.0M). Over the past eight quarters, CRYO CELL INTERNATIONAL INC's revenue compounded faster (-0.1% CAGR vs -13.5%).

Aterian, Inc. is a technology-enabled consumer products company that leverages artificial intelligence and data analytics to identify market demand, develop, source and distribute a wide portfolio of affordable goods spanning home improvement, wellness, personal care, pet supplies and outdoor recreation. It primarily sells its products through leading global e-commerce platforms, with core markets covering North America and Europe.

Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.

ATER vs CCEL — Head-to-Head

Bigger by revenue
ATER
ATER
1.9× larger
ATER
$15.1M
$7.8M
CCEL
Growing faster (revenue YoY)
CCEL
CCEL
+36.2% gap
CCEL
-2.3%
-38.5%
ATER
Higher net margin
CCEL
CCEL
3.8% more per $
CCEL
-48.7%
-52.5%
ATER
More free cash flow
CCEL
CCEL
$2.3M more FCF
CCEL
$1.2M
$-1.0M
ATER
Faster 2-yr revenue CAGR
CCEL
CCEL
Annualised
CCEL
-0.1%
-13.5%
ATER

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ATER
ATER
CCEL
CCEL
Revenue
$15.1M
$7.8M
Net Profit
$-7.9M
$-3.8M
Gross Margin
56.1%
77.9%
Operating Margin
-51.1%
-50.6%
Net Margin
-52.5%
-48.7%
Revenue YoY
-38.5%
-2.3%
Net Profit YoY
-512.2%
-105.1%
EPS (diluted)
$-0.46

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ATER
ATER
CCEL
CCEL
Q4 25
$15.1M
$7.8M
Q3 25
$19.0M
$7.8M
Q2 25
$19.5M
$7.9M
Q1 25
$15.4M
$8.0M
Q4 24
$24.6M
$8.0M
Q3 24
$26.2M
$8.1M
Q2 24
$28.0M
$8.0M
Q1 24
$20.2M
$7.9M
Net Profit
ATER
ATER
CCEL
CCEL
Q4 25
$-7.9M
$-3.8M
Q3 25
$-2.3M
$749.4K
Q2 25
$-4.9M
$355.8K
Q1 25
$-3.9M
$282.9K
Q4 24
$-1.3M
$-1.9M
Q3 24
$-1.8M
$1.1M
Q2 24
$-3.6M
$655.8K
Q1 24
$-5.2M
$556.2K
Gross Margin
ATER
ATER
CCEL
CCEL
Q4 25
56.1%
77.9%
Q3 25
56.1%
77.0%
Q2 25
54.3%
76.6%
Q1 25
61.4%
75.1%
Q4 24
63.4%
78.4%
Q3 24
60.3%
73.6%
Q2 24
60.4%
74.8%
Q1 24
65.1%
73.7%
Operating Margin
ATER
ATER
CCEL
CCEL
Q4 25
-51.1%
-50.6%
Q3 25
-10.7%
24.3%
Q2 25
-23.1%
18.8%
Q1 25
-24.1%
13.3%
Q4 24
-6.5%
-1.5%
Q3 24
-6.6%
17.2%
Q2 24
-11.5%
17.3%
Q1 24
-26.1%
10.5%
Net Margin
ATER
ATER
CCEL
CCEL
Q4 25
-52.5%
-48.7%
Q3 25
-12.0%
9.6%
Q2 25
-25.0%
4.5%
Q1 25
-25.4%
3.5%
Q4 24
-5.3%
-23.2%
Q3 24
-6.8%
13.0%
Q2 24
-13.0%
8.2%
Q1 24
-25.5%
7.1%
EPS (diluted)
ATER
ATER
CCEL
CCEL
Q4 25
$-0.46
Q3 25
$0.09
Q2 25
$0.04
Q1 25
$0.03
Q4 24
$-0.23
Q3 24
$0.13
Q2 24
$0.08
Q1 24
$0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ATER
ATER
CCEL
CCEL
Cash + ST InvestmentsLiquidity on hand
$4.9M
$3.3M
Total DebtLower is stronger
$8.4M
Stockholders' EquityBook value
$15.2M
$-18.6M
Total Assets
$29.6M
$61.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ATER
ATER
CCEL
CCEL
Q4 25
$4.9M
$3.3M
Q3 25
$7.6M
$3.2M
Q2 25
$10.5M
$4.4M
Q1 25
$14.3M
$3.5M
Q4 24
$18.0M
$3.5M
Q3 24
$16.1M
$2.1M
Q2 24
$20.3M
$1.5M
Q1 24
$17.5M
$979.6K
Total Debt
ATER
ATER
CCEL
CCEL
Q4 25
$8.4M
Q3 25
$8.4M
Q2 25
$8.4M
Q1 25
$8.5M
Q4 24
$8.5M
Q3 24
$8.5M
Q2 24
$8.5M
Q1 24
$8.6M
Stockholders' Equity
ATER
ATER
CCEL
CCEL
Q4 25
$15.2M
$-18.6M
Q3 25
$22.6M
$-14.8M
Q2 25
$24.3M
$-15.6M
Q1 25
$27.0M
$-14.7M
Q4 24
$30.0M
$-13.2M
Q3 24
$30.6M
$-9.6M
Q2 24
$30.9M
$-10.7M
Q1 24
$33.0M
$-10.3M
Total Assets
ATER
ATER
CCEL
CCEL
Q4 25
$29.6M
$61.7M
Q3 25
$40.1M
$63.2M
Q2 25
$45.4M
$64.4M
Q1 25
$49.8M
$64.4M
Q4 24
$49.5M
$64.7M
Q3 24
$52.1M
$62.9M
Q2 24
$59.9M
$62.6M
Q1 24
$55.7M
$61.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ATER
ATER
CCEL
CCEL
Operating Cash FlowLast quarter
$-1.0M
$1.3M
Free Cash FlowOCF − Capex
$-1.0M
$1.2M
FCF MarginFCF / Revenue
-6.9%
15.5%
Capex IntensityCapex / Revenue
0.0%
0.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$5.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ATER
ATER
CCEL
CCEL
Q4 25
$-1.0M
$1.3M
Q3 25
$-1.6M
$2.5M
Q2 25
$-4.4M
$707.0K
Q1 25
$-3.9M
$954.1K
Q4 24
$-9.0K
$2.2M
Q3 24
$-722.0K
$2.4M
Q2 24
$2.9M
$1.8M
Q1 24
$-6.0K
$-356.9K
Free Cash Flow
ATER
ATER
CCEL
CCEL
Q4 25
$-1.0M
$1.2M
Q3 25
$-1.6M
$2.5M
Q2 25
$-4.4M
$644.6K
Q1 25
$892.0K
Q4 24
$2.1M
Q3 24
$2.3M
Q2 24
$2.9M
$21.5K
Q1 24
$-42.0K
$-814.6K
FCF Margin
ATER
ATER
CCEL
CCEL
Q4 25
-6.9%
15.5%
Q3 25
-8.4%
31.9%
Q2 25
-22.7%
8.1%
Q1 25
11.2%
Q4 24
26.8%
Q3 24
27.9%
Q2 24
10.3%
0.3%
Q1 24
-0.2%
-10.4%
Capex Intensity
ATER
ATER
CCEL
CCEL
Q4 25
0.0%
0.9%
Q3 25
0.2%
0.5%
Q2 25
0.0%
0.8%
Q1 25
0.0%
0.8%
Q4 24
0.0%
0.1%
Q3 24
0.0%
2.3%
Q2 24
0.0%
21.8%
Q1 24
0.2%
5.8%
Cash Conversion
ATER
ATER
CCEL
CCEL
Q4 25
Q3 25
3.38×
Q2 25
1.99×
Q1 25
3.37×
Q4 24
Q3 24
2.32×
Q2 24
2.70×
Q1 24
-0.64×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ATER
ATER

Sales Channel Directly To Consumer$13.1M87%
Heating Cooling And Air Quality$2.1M14%

CCEL
CCEL

Segment breakdown not available.

Related Comparisons